The area under ROC curve of the TCGA cohort was 0.976 in TFAP2A, implying a highly accurate predictive power of TFAP2A in pancreatic cancer (Supplementary Figure 2B). The gene discussed is TFAP2A; the disease is pancreatic neoplasm.